Published in Nat Genet on September 04, 2011
MicroRNAs in stress signaling and human disease. Cell (2012) 6.93
Defining the role of common variation in the genomic and biological architecture of adult human height. Nat Genet (2014) 5.78
MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov (2013) 3.33
MicroRNAs in human cancer. Adv Exp Med Biol (2013) 3.19
The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease. Cell Death Differ (2013) 2.41
Modulation of the osteosarcoma expression phenotype by microRNAs. PLoS One (2012) 2.06
The role of miRNAs in regulating gene expression networks. J Mol Biol (2013) 1.74
mir-17-92 cluster is required for and sufficient to induce cardiomyocyte proliferation in postnatal and adult hearts. Circ Res (2013) 1.72
Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo. J Exp Med (2013) 1.71
The biological functions of miRNAs: lessons from in vivo studies. Trends Cell Biol (2014) 1.47
Growth and folding of the mammalian cerebral cortex: from molecules to malformations. Nat Rev Neurosci (2014) 1.44
The microRNA-17-92 family of microRNA clusters in development and disease. Cancer J (2012) 1.42
Genome-wide identification of miRNA targets by PAR-CLIP. Methods (2012) 1.16
MicroRNAs: new players in IBD. Gut (2014) 1.07
microRNA-17-92 regulates IL-10 production by regulatory T cells and control of experimental autoimmune encephalomyelitis. J Immunol (2013) 1.05
Regulation of miRNA biogenesis and turnover in the immune system. Immunol Rev (2013) 1.00
MicroRNA-17-92 cluster mediates the proliferation and survival of neural progenitor cells after stroke. J Biol Chem (2013) 0.99
Comparative transcriptome analysis of epithelial and fiber cells in newborn mouse lenses with RNA sequencing. Mol Vis (2014) 0.99
MicroRNA-17-92, a direct Ap-2α transcriptional target, modulates T-box factor activity in orofacial clefting. PLoS Genet (2013) 0.98
Outside the coding genome, mammalian microRNAs confer structural and functional complexity. Sci Signal (2015) 0.97
Signature MicroRNA expression patterns identified in humans with 22q11.2 deletion/DiGeorge syndrome. Clin Immunol (2013) 0.96
Control of vertebrate development by MYC. Cold Spring Harb Perspect Med (2013) 0.94
MicroRNA-17~92 is required for nephrogenesis and renal function. J Am Soc Nephrol (2014) 0.93
MicroRNAs involved in bone formation. Cell Mol Life Sci (2014) 0.92
An allelic series of miR-17 ∼ 92-mutant mice uncovers functional specialization and cooperation among members of a microRNA polycistron. Nat Genet (2015) 0.92
Mutation in a primate-conserved retrotransposon reveals a noncoding RNA as a mediator of infantile encephalopathy. Proc Natl Acad Sci U S A (2012) 0.91
MicroRNAs as regulators of bone homeostasis and bone metastasis. Bonekey Rep (2014) 0.90
MicroRNAs in cerebral ischemia-induced neurogenesis. J Neuropathol Exp Neurol (2013) 0.89
Inherited variation in miR-290 expression suppresses breast cancer progression by targeting the metastasis susceptibility gene Arid4b. Cancer Res (2013) 0.89
MicroRNA expression profiling of the developing murine upper lip. Dev Growth Differ (2014) 0.87
A Biogenesis Step Upstream of Microprocessor Controls miR-17∼92 Expression. Cell (2015) 0.85
A serum microRNA signature associated with complete remission and progression after autologous stem-cell transplantation in patients with multiple myeloma. Oncotarget (2015) 0.85
Insights into Regulation of the miR-17-92 Cluster of miRNAs in Cancer. Front Med (Lausanne) (2015) 0.85
A new plasmid-based microRNA inhibitor system that inhibits microRNA families in transgenic mice and cells: a potential new therapeutic reagent. Gene Ther (2016) 0.84
Phenotypic characterization of miR-92a-/- mice reveals an important function of miR-92a in skeletal development. PLoS One (2014) 0.84
12p microRNA expression in fibroblast cell lines from probands with Pallister-Killian syndrome. Chromosome Res (2014) 0.84
Loss of microRNA-7a2 induces hypogonadotropic hypogonadism and infertility. J Clin Invest (2017) 0.84
Embryonic stem cell miRNAs and their roles in development and disease. Semin Cancer Biol (2012) 0.84
Copy number variation analysis implicates the cell polarity gene glypican 5 as a human spina bifida candidate gene. Hum Mol Genet (2012) 0.84
Vitamin D and microRNAs in bone. Crit Rev Eukaryot Gene Expr (2013) 0.83
Short stature, digit anomalies and dysmorphic facial features are associated with the duplication of miR-17 ~ 92 cluster. Mol Cytogenet (2014) 0.83
miRNA and miRNA target genes in copy number variations occurring in individuals with intellectual disability. BMC Genomics (2013) 0.82
Promoting brain remodeling to aid in stroke recovery. Trends Mol Med (2015) 0.82
Haploinsufficiency of Tumor Suppressor Genes is Driven by the Cumulative Effect of microRNAs, microRNA Binding Site Polymorphisms and microRNA Polymorphisms: An In silico Approach. Cancer Inform (2012) 0.82
miRConnect 2.0: identification of oncogenic, antagonistic miRNA families in three human cancers. BMC Genomics (2013) 0.81
MiR-17 Downregulation by High Glucose Stabilizes Thioredoxin-Interacting Protein and Removes Thioredoxin Inhibition on ASK1 Leading to Apoptosis. Toxicol Sci (2015) 0.81
RAS-MAPK pathway epigenetic activation in cancer: miRNAs in action. Oncotarget (2016) 0.81
Epigenetic mechanisms underlying the pathogenesis of neurogenetic diseases. Neurotherapeutics (2014) 0.80
miRBoost: boosting support vector machines for microRNA precursor classification. RNA (2015) 0.80
Transfection of microRNA Mimics Should Be Used with Caution. Front Genet (2015) 0.80
Role of the miR-17∼92 cluster family in cerebellar and medulloblastoma development. Biol Open (2014) 0.80
MicroRNA 19a replacement partially rescues fin and cardiac defects in zebrafish model of Holt Oram syndrome. Sci Rep (2015) 0.79
Retinoic acid-dependent regulation of miR-19 expression elicits vertebrate axis defects. FASEB J (2013) 0.79
MicroRNAs in the pathogenesis of cystic kidney disease. Curr Opin Pediatr (2015) 0.79
MicroRNAs: potential regulators of renal development genes that contribute to CAKUT. Pediatr Nephrol (2013) 0.78
Differentially expressed microRNAs in chondrocytes from distinct regions of developing human cartilage. PLoS One (2013) 0.78
MicroRNA-based screens for synthetic lethal interactions with c-Myc. RNA Dis (2016) 0.78
A genome-wide association study of variations in maternal cardiometabolic genes and risk of placental abruption. Int J Mol Epidemiol Genet (2012) 0.78
Targeting microRNAs for immunomodulation. Curr Opin Pharmacol (2015) 0.78
Using height association studies to gain insights into human idiopathic short and syndromic stature phenotypes. Pediatr Nephrol (2012) 0.77
lin28 proteins promote expression of 17∼92 family miRNAs during amphibian development. Dev Dyn (2015) 0.77
A fourth case of Feingold syndrome type 2: psychiatric presentation and management. BMJ Case Rep (2014) 0.77
An Improved microRNA Annotation of the Canine Genome. PLoS One (2016) 0.77
Common miR-590 Variant rs6971711 Present Only in African Americans Reduces miR-590 Biogenesis. PLoS One (2016) 0.77
MicroRNA Profiling during Craniofacial Development: Potential Roles for Mir23b and Mir133b. Front Physiol (2016) 0.76
Targeted sequencing of 96 renal developmental microRNAs in 1213 individuals from 980 families with congenital anomalies of the kidney and urinary tract. Nephrol Dial Transplant (2016) 0.76
Runx2/DICER/miRNA Pathway in Regulating Osteogenesis. J Cell Physiol (2016) 0.76
Isolation and detection of microRNA from the egg of chickens. BMC Res Notes (2016) 0.75
Bone marrow stroma-derived miRNAs as regulators, biomarkers and therapeutic targets of bone metastasis. Bonekey Rep (2015) 0.75
Control of T(FH) differentiation by a microRNA cluster. Nat Immunol (2013) 0.75
miRNAs in Bone Development. Curr Genomics (2015) 0.75
Short intron-derived ncRNAs. Nucleic Acids Res (2017) 0.75
Neurobehavioral Alterations in a Genetic Murine Model of Feingold Syndrome 2. Behav Genet (2015) 0.75
MicroRNA degeneracy and pluripotentiality within a Lavallière-tie architecture confers robustness to gene expression networks. Cell Mol Life Sci (2016) 0.75
Renal dysplasia in the neonate. Curr Opin Pediatr (2016) 0.75
A role for miR-19 in the migration of adult-born neurons and schizophrenia. Neurogenesis (Austin) (2016) 0.75
Functional interactions among members of the miR-17-92 cluster in lymphocyte development, differentiation and malignant transformation. Int Immunopharmacol (2015) 0.75
A mouse model of MYCN-driven retinoblastoma reveals MYCN-independent tumor reemergence. J Clin Invest (2017) 0.75
Conditional disruption of miR17-92 cluster in collagen type I-producing osteoblasts results in reduced periosteal bone formation and bone anabolic response to exercise. Physiol Genomics (2014) 0.75
The anti-melanoma activity and oncogenic targets of hsa-miR-15a-5p. RNA Dis (2016) 0.75
MicroRNAs in Palatogenesis and Cleft Palate. Front Physiol (2017) 0.75
Chromosome 13q deletion syndrome involving 13q31‑qter: A case report. Mol Med Rep (2017) 0.75
MicroRNA-495 Inhibits New Bone Regeneration via Targeting High Mobility Group AT-Hook 2 (HMGA2). Med Sci Monit (2017) 0.75
Identification of new susceptibility loci for type 2 diabetes and shared etiological pathways with coronary heart disease. Nat Genet (2017) 0.75
Detection of large-scale variation in the human genome. Nat Genet (2004) 49.18
A microRNA polycistron as a potential human oncogene. Nature (2005) 40.21
A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A (2006) 40.09
c-Myc-regulated microRNAs modulate E2F1 expression. Nature (2005) 31.81
Mapping and sequencing of structural variation from eight human genomes. Nature (2008) 30.28
Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell (2008) 28.29
Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell (2008) 12.29
A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res (2005) 10.46
Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res (2004) 7.96
DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources. Am J Hum Genet (2009) 7.61
Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet (2006) 7.53
miR-19 is a key oncogenic component of mir-17-92. Genes Dev (2009) 4.95
Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes Dev (2009) 4.43
Mutations in the seed region of human miR-96 are responsible for nonsyndromic progressive hearing loss. Nat Genet (2009) 3.72
Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM. PLoS One (2008) 3.68
The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. Cancer Res (2009) 3.03
MYCN regulates oncogenic MicroRNAs in neuroblastoma. Int J Cancer (2008) 2.76
The miR-17~92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma. Proc Natl Acad Sci U S A (2009) 2.72
Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop. Genes Dev (1992) 2.54
The miR-17-92 microRNA cluster regulates multiple components of the TGF-β pathway in neuroblastoma. Mol Cell (2010) 2.38
A microRNA cluster as a target of genomic amplification in malignant lymphoma. Leukemia (2005) 2.19
The myc-miR-17~92 axis blunts TGF{beta} signaling and production of multiple TGF{beta}-dependent antiangiogenic factors. Cancer Res (2010) 2.13
Dissecting the role of N-myc in development using a single targeting vector to generate a series of alleles. Curr Biol (1998) 2.02
Defects of embryonic organogenesis resulting from targeted disruption of the N-myc gene in the mouse. Development (1993) 1.55
MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma. Proc Natl Acad Sci U S A (2010) 1.49
A targeted mutation reveals a role for N-myc in branching morphogenesis in the embryonic mouse lung. Genes Dev (1992) 1.40
MYCN haploinsufficiency is associated with reduced brain size and intestinal atresias in Feingold syndrome. Nat Genet (2005) 1.36
Genotype-phenotype correlations in MYCN-related Feingold syndrome. Hum Mutat (2008) 1.24
Twelve new patients with 13q deletion syndrome: genotype-phenotype analyses in progress. Eur J Med Genet (2008) 1.19
Feingold syndrome: clinical review and genetic mapping. Am J Med Genet A (2003) 1.15
Delineation of 15q13.3 microdeletions. Clin Genet (2010) 1.13
Activities of N-Myc in the developing limb link control of skeletal size with digit separation. Development (2007) 0.99
Syndrome of microcephaly, facial and hand abnormalities, tracheoesophageal fistula, duodenal atresia, and developmental delay. Am J Med Genet (1997) 0.93
Dissection of the MYCN locus in Feingold syndrome and isolated oesophageal atresia. Eur J Hum Genet (2011) 0.89
Interstitial deletion of 13q22-->q31: case report and review of the literature. Clin Dysmorphol (2006) 0.81
Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med (2006) 9.50
Lamin a truncation in Hutchinson-Gilford progeria. Science (2003) 8.01
The revised Ghent nosology for the Marfan syndrome. J Med Genet (2010) 6.87
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma. Nature (2008) 5.32
Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion. Nat Genet (2007) 4.99
Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA (2011) 4.84
The ciliary gene RPGRIP1L is mutated in cerebello-oculo-renal syndrome (Joubert syndrome type B) and Meckel syndrome. Nat Genet (2007) 4.63
Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes Dev (2009) 4.43
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome. Nat Genet (2003) 3.96
A central role for HER3 in HER2-amplified breast cancer: implications for targeted therapy. Cancer Res (2008) 3.93
Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J Exp Med (2008) 3.85
Mutations in TMEM216 perturb ciliogenesis and cause Joubert, Meckel and related syndromes. Nat Genet (2010) 3.66
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma. Nature (2011) 3.53
Pleiotropic effects of CEP290 (NPHP6) mutations extend to Meckel syndrome. Am J Hum Genet (2007) 3.42
A non-genetic route to aneuploidy in human cancers. Nat Cell Biol (2011) 3.25
Leber congenital amaurosis: comprehensive survey of the genetic heterogeneity, refinement of the clinical definition, and genotype-phenotype correlations as a strategy for molecular diagnosis. Hum Mutat (2004) 3.07
Segregation at three loci explains familial and population risk in Hirschsprung disease. Nat Genet (2002) 3.07
Highly conserved non-coding elements on either side of SOX9 associated with Pierre Robin sequence. Nat Genet (2009) 3.03
Widespread regulatory activity of vertebrate microRNA* species. RNA (2010) 2.97
The Meckel-Gruber syndrome gene, MKS3, is mutated in Joubert syndrome. Am J Hum Genet (2006) 2.96
Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med (2011) 2.93
De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy. Nat Genet (2012) 2.86
Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation. Arch Gen Psychiatry (2009) 2.82
Human neural tube defects: developmental biology, epidemiology, and genetics. Neurotoxicol Teratol (2005) 2.62
miR-122, a paradigm for the role of microRNAs in the liver. J Hepatol (2008) 2.61
Truncating mutations in the last exon of NOTCH2 cause a rare skeletal disorder with osteoporosis. Nat Genet (2011) 2.61
Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus. Nature (2011) 2.59
A p53-p66Shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosis. Oncogene (2002) 2.55
Mutations at a single codon in Mad homology 2 domain of SMAD4 cause Myhre syndrome. Nat Genet (2011) 2.52
Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA). Ann Neurol (2010) 2.48
Familial Mediterranean fever among patients from Karabakh and the diagnostic value of MEFV gene analysis in all classically affected populations. Arthritis Rheum (2003) 2.32
Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects. Mol Aspects Med (2004) 2.32
Loss-of-function mutations in euchromatin histone methyl transferase 1 (EHMT1) cause the 9q34 subtelomeric deletion syndrome. Am J Hum Genet (2006) 2.31
Large spectrum of lissencephaly and pachygyria phenotypes resulting from de novo missense mutations in tubulin alpha 1A (TUBA1A). Hum Mutat (2007) 2.24
Mutations in TCF4, encoding a class I basic helix-loop-helix transcription factor, are responsible for Pitt-Hopkins syndrome, a severe epileptic encephalopathy associated with autonomic dysfunction. Am J Hum Genet (2007) 2.22
ADAMTS10 mutations in autosomal recessive Weill-Marchesani syndrome. Am J Hum Genet (2004) 2.22
A human mutation in Phox2b causes lack of CO2 chemosensitivity, fatal central apnea, and specific loss of parafacial neurons. Proc Natl Acad Sci U S A (2008) 2.19
Differential contributions of rare and common, coding and noncoding Ret mutations to multifactorial Hirschsprung disease liability. Am J Hum Genet (2010) 2.12
Identification of mutations in CUL7 in 3-M syndrome. Nat Genet (2005) 2.10
Loss-of-function mutation in the dioxygenase-encoding FTO gene causes severe growth retardation and multiple malformations. Am J Hum Genet (2009) 2.09
Mutations in TUBG1, DYNC1H1, KIF5C and KIF2A cause malformations of cortical development and microcephaly. Nat Genet (2013) 2.06
Spectrum of NPHP6/CEP290 mutations in Leber congenital amaurosis and delineation of the associated phenotype. Hum Mutat (2007) 2.04
DYNC2H1 mutations cause asphyxiating thoracic dystrophy and short rib-polydactyly syndrome, type III. Am J Hum Genet (2009) 2.03
Homozygous silencing of T-box transcription factor EOMES leads to microcephaly with polymicrogyria and corpus callosum agenesis. Nat Genet (2007) 2.03
Capture of microRNA-bound mRNAs identifies the tumor suppressor miR-34a as a regulator of growth factor signaling. PLoS Genet (2011) 2.00
Succinate dehydrogenase and human diseases: new insights into a well-known enzyme. Eur J Hum Genet (2002) 2.00
Claudin-1 gene mutations in neonatal sclerosing cholangitis associated with ichthyosis: a tight junction disease. Gastroenterology (2004) 1.98
The MAPK(ERK-1,2) pathway integrates distinct and antagonistic signals from TGFalpha and FGF7 in morphogenesis of mouse mammary epithelium. Dev Biol (2007) 1.98
Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma. Am J Hum Genet (2004) 1.98
Lamin A and ZMPSTE24 (FACE-1) defects cause nuclear disorganization and identify restrictive dermopathy as a lethal neonatal laminopathy. Hum Mol Genet (2004) 1.94
High expression levels of total IGF-1R and sensitivity of NSCLC cells in vitro to an anti-IGF-1R antibody (R1507). PLoS One (2009) 1.93
Spectrum of MKS1 and MKS3 mutations in Meckel syndrome: a genotype-phenotype correlation. Mutation in brief #960. Online. Hum Mutat (2007) 1.93
Tequila, a neurotrypsin ortholog, regulates long-term memory formation in Drosophila. Science (2006) 1.93
A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency. J Clin Invest (2003) 1.92
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Res (2010) 1.90
Genotype-phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21. Eur J Hum Genet (2008) 1.90
Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome. J Med Genet (2007) 1.89
CABC1 gene mutations cause ubiquinone deficiency with cerebellar ataxia and seizures. Am J Hum Genet (2008) 1.86
Matthew-Wood syndrome is caused by truncating mutations in the retinol-binding protein receptor gene STRA6. Am J Hum Genet (2007) 1.86
Selective iron chelation in Friedreich ataxia: biologic and clinical implications. Blood (2007) 1.84
Segregation of mtDNA throughout human embryofetal development: m.3243A>G as a model system. Hum Mutat (2011) 1.83